TipRanks
Enorama Pharma AB (SE:ERMA)
:ERMA
Sweden Market
ERMA
Enorama Pharma AB
RESEARCH TOOLSreports
Want to see SE:ERMA full AI Analyst Report?

Enorama Pharma AB (ERMA) Ratios

0 Followers

Enorama Pharma AB Ratios

SE:ERMA's free cash flow for Q2 2026 was kr0.00. For the 2026 fiscal year, SE:ERMA's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.21 0.25 1.87 1.27 0.95
Quick Ratio
 0.16 0.20 0.48 0.85 0.72
Cash Ratio
 0.06 0.10 0.26 0.60 0.33
Solvency Ratio
 -1.03 -2.35 -2.89 -2.96 -2.22
Operating Cash Flow Ratio
 -1.62 -1.87 -4.41 -4.05 -2.65
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 -310.89 -22.51
Net Current Asset Value
kr -50.53Mkr -23.72Mkr 7.07Mkr -1.88Mkr -5.45M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.01 0.04
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.02 0.06
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.02 0.06
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.02 0.01
Financial Leverage Ratio
 -0.14 -0.35 2.04 1.76 1.55
Debt Service Coverage Ratio
 -6.19 -4.88 -6.82 -42.38 -13.51
Interest Coverage Ratio
 -6.22 -4.91 -15.89 -47.38 -32.58
Debt to Market Cap
 0.00 0.00 0.00 <0.01 0.07
Interest Debt Per Share
 0.12 0.18 0.06 0.04 0.34
Net Debt to EBITDA
 0.04 0.05 0.10 0.13 0.06
Profitability Margins
Gross Profit Margin
-2955.18%-2255.60%23.48%-287.26%-9.00%
EBIT Margin
-3763.26%-2267.98%-258.85%-3220.18%-595.25%
EBITDA Margin
-3738.33%-2250.86%-129.41%-3170.32%-543.60%
Operating Profit Margin
-3757.87%-2267.98%-301.34%-3080.85%-605.67%
Pretax Profit Margin
-4121.55%-2743.30%-277.82%-3285.20%-613.85%
Net Profit Margin
-4121.55%-2743.30%-277.82%-3285.20%-610.19%
Continuous Operations Profit Margin
-4121.55%-2743.30%-277.82%-3285.20%-613.85%
Net Income Per EBT
100.00%100.00%100.00%100.00%99.41%
EBT Per EBIT
109.68%120.96%92.19%106.63%101.35%
Return on Assets (ROA)
-858.46%-909.45%-275.61%-129.75%-85.75%
Return on Equity (ROE)
207.27%320.41%-561.40%-228.34%-132.53%
Return on Capital Employed (ROCE)
210.96%264.89%-608.93%-173.12%-114.26%
Return on Invested Capital (ROIC)
210.96%264.89%-608.93%-172.17%-109.17%
Return on Tangible Assets
-869.08%-938.30%-286.28%-322.67%-165.20%
Earnings Yield
-113.01%-56.62%-24.58%-52.92%-149.27%
Efficiency Ratios
Receivables Turnover
 0.47 1.03 11.19 0.66 1.58
Payables Turnover
 22.92 9.92 10.33 1.41 1.39
Inventory Turnover
 26.02 36.87 1.07 1.23 2.63
Fixed Asset Turnover
 0.00 228.25 111.04 1.58 4.45
Asset Turnover
 0.21 0.33 0.99 0.04 0.14
Working Capital Turnover Ratio
 -0.08 -0.33 3.21 1.31 1.36
Cash Conversion Cycle
 771.71 325.86 338.38 591.17 107.34
Days of Sales Outstanding
 773.61 352.74 32.62 551.26 230.40
Days of Inventory Outstanding
 14.03 9.90 341.10 297.89 138.75
Days of Payables Outstanding
 15.92 36.78 35.34 257.98 261.80
Operating Cycle
 787.63 362.64 373.72 849.15 369.15
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.71 -0.85 -0.67 -1.23 -3.47
Free Cash Flow Per Share
 -0.71 -0.85 -0.67 -1.23 -3.47
CapEx Per Share
 0.20 0.85 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -3.59 -1.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 -3.59 -1.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 -94.84 -17.26
Operating Cash Flow to Sales Ratio
 -36.64 -21.64 -2.26 -30.45 -4.81
Free Cash Flow Yield
-100.45%-44.66%-20.03%-49.05%-117.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.87 -1.77 -4.05 -1.89 -0.67
Price-to-Sales (P/S) Ratio
 36.47 48.45 11.30 62.07 4.09
Price-to-Book (P/B) Ratio
 -1.05 -5.66 22.84 4.31 0.89
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.00 -2.24 -4.99 -2.04 -0.85
Price-to-Operating Cash Flow Ratio
 -1.00 -2.24 -4.99 -2.04 -0.85
Price-to-Earnings Growth (PEG) Ratio
 -0.03 -0.06 0.11 0.03 -0.04
Price-to-Fair Value
 -1.05 -5.66 22.84 4.31 0.89
Enterprise Value Multiple
 -0.94 -2.10 -8.63 -1.83 -0.69
Enterprise Value
 50.71M 129.66M 176.12M 78.58M 25.76M
EV to EBITDA
 -0.94 -2.10 -8.63 -1.83 -0.69
EV to Sales
 35.02 47.34 11.17 57.86 3.76
EV to Free Cash Flow
 -0.96 -2.19 -4.93 -1.90 -0.78
EV to Operating Cash Flow
 -0.96 -2.19 -4.93 -1.90 -0.78
Tangible Book Value Per Share
 -0.68 -0.34 0.14 -0.03 0.85
Shareholders’ Equity Per Share
 -0.68 -0.34 0.15 0.58 3.32
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 <0.01
Revenue Per Share
 0.02 0.04 0.30 0.04 0.72
Net Income Per Share
 -0.80 -1.08 -0.83 -1.33 -4.40
Tax Burden
 1.00 1.00 1.00 1.00 0.99
Interest Burden
 1.10 1.21 1.07 1.02 1.03
Research & Development to Revenue
 0.00 0.00 1.27 2.11 0.42
SG&A to Revenue
 8.03 0.00 1.97 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.89 0.79 0.75 0.93 0.79
Currency in SEK